Intervention not reported
5‐ASA (3 RCTs; 237 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes 5‐ASA (3 RCTs; 237 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Placebo (8 RCTs; 507 participants) · surgically induced remission in Crohn's disease
1 finding from 1 review
Intervention not reported
Sulfasalazine (1 RCT; 32 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes sulfasalazine (1 RCT; 32 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Infliximab (1 RCT; 11 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes infliximab (1 RCT; 11 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
5‐ASA (8 RCTs; 371 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes 5‐ASA (8 RCTs; 371 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Budesonide (2 RCTs; 106 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes budesonide (2 RCTs; 106 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Probiotic (1 RCT; 58 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes probiotic (1 RCT; 58 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Adalimumab (1 RCT; 16 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes adalimumab (1 RCT; 16 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Purine analogues (7 RCTs; 315 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes purine analogues (7 RCTs; 315 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Antibiotics (1 RCT; 16 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes antibiotics (1 RCT; 16 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Rank 5 (3 to 7) · surgically induced remission in Crohn's disease
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Placebo (10 RCTs; 531 participants) · surgically induced remission in Crohn's disease
1 finding from 1 review
Intervention not reported
Rank 4 (2 to 7) · surgically induced remission in Crohn's disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Adalimumab (2 RCTs; 26 participants) · surgically induced remission in Crohn's disease
The intervention may leads to lower adalimumab (2 RCTs; 26 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Infliximab (2 RCTs; 21 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes infliximab (2 RCTs; 21 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Budesonide (1 RCT; 43 participants) · surgically induced remission in Crohn's disease
The intervention showed no clear difference in budesonide (1 RCT; 43 participants) (low certainty).
1 finding from 1 review
Intervention not reported
5‐ASA (9 RCTs; 542 participants) · surgically induced remission in Crohn's disease
The intervention probably leads to lower 5‐ASA (9 RCTs; 542 participants) (moderate certainty).
1 finding from 1 review
Intervention not reported
Purine analogues (6 RCTs; 316 participants) · surgically induced remission in Crohn's disease
The intervention showed no clear difference in purine analogues (6 RCTs; 316 participants) (low certainty).
1 finding from 1 review
Death or dependence · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling probably leads to lower poor outcome: death or dependence in daily activities (12 months) compared with neurosurgical clipping (moderate certainty).
2 findings from 1 review
Death from any cause (12 months) · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling showed no clear difference in death from any cause (12 months) compared with neurosurgical clipping (moderate certainty).
1 finding from 1 review